That's essential, due to the fact that the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be reliable. In other words, we have to know how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error process (jeff brown genome sequencing stock). Today, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much easier to produce drugs that do what they're created to do. This was a breakthrough almost no one observed. But it's going to have profound ramifications for treating disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be plenty of financial investment opportunities in this area, too. Shifting topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown top biotech 2020). That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it pulled back maybe considerably before going greater - the legacy report prediction. I've been covering bitcoin for a long time now. Among the very first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mainly educating readers. But that's not the big concern any longer. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a relied on 170-year-old organization. So consider that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. tech predictions. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are numerous fantastic private companies on the edge of hitting the general public markets And I have actually been dealing with a brand-new method for you to invest even prior to these companies go public.
This opportunity has been constructing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the details. Go right here to book your area free of charge.
Emma Walsh here, managing editor of the Journal. Routine Journal readers understand that tech isn't our typical beat (self-driving cars). And when it pertains to tech investing, we leave it to the experts. Fortunately, we have several such specialists in our Rolodex. Our colleague Jeff Brown will be familiar to our long time readers. He is among the most accomplished tech investing specialists we understand (united states). In fact, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge image and forecast what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and a lot more. These patterns are experiencing rapid growth and producing amazing opportunities for financiers. I wish to make sure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. exponential growth. However regardless of what many readers may believe, this is a trend that's just getting started. Although the COVID-19 pandemic disrupted supply chains in 2015, a remarkable 250 million 5G-enabled devices were still sold.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by two months (social media). Losing two months of manufacturing and sales truly affects how numerous 5G devices are sold in the calendar year. When you consider all of that, offering 250 million units is remarkable. More notably, the hold-ups brought on by the pandemic created a load of pent-up demand. And that demand is now going to be pushed into 2021. In reality, I anticipate that more than 500 million 5G devices will be delivered in 2021 - jeff brown biotech genome sequencing. And that's not my only 5G forecast When I have actually talked about 5G in the past, I've described its 3 different stages.
In Phase 2, 5G gadgets go on sale. 5G phones and other products start to reach consumers. And in Stage 3, 5G services start to be used (last year). That's when we begin to see applications operating on 5G networks. Think about things like massive multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Stage 3 by this summer. This starts something of a virtuous cycle: The majority of individuals do not actually care about the technology. But they will care if there are exciting applications that can just be accessed with a 5G phone.
That leads to more 5G apps being established. In reality, 5G is going to open a suite of amazing applications: self-driving cars and trucks, the Internet of Things, robotic surgical treatment, and more. All of these technologies need 5G. The financial investment opportunities going forward will be enormous. Stepping far from 5G, the next essential innovation I foresee in 2021 is CRISPR genetic modifying. CRISPR represents "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it is among the most interesting advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our genetic makeup as if it were software.
The program can crash or not function correctly. CRISPR uses a comparable idea but with our genetic code. "Typos" in our genome can lead to disease. CRISPR can remedy these "typos." For several years, CRISPR was primarily a specific niche innovation that wasn't well comprehended. And throughout that time, there were truly just 3 companies running in this space. But things are altering. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're dealing with illness and seeing that this technology simply works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and delivering incredible returns. This whole market is effectively a greenfield opportunity.
There's space for many companies to exist in this space. legacy report prediction. And there will be more. That's my forecast for CRISPR in 2021. I forecast that two or 3 more genetic editing companies will hold their IPOs. Sticking to biotechnology, we are seeing amazing things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its latest Alpha, Fold software can accurately anticipate the folding of a protein based solely on its amino acid series with 92. 4% accuracy. That's important due to the fact that the way a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and be reliable.
Historically, this has actually been an experimental process. But now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're developed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but numerous drug therapies produced utilizing this innovation. This was one of those breakthroughs that almost nobody observed. However it's going to have profound ramifications for treating illness. And, naturally, there will be a lot of financial investment chances in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it drew back possibly substantially before going higher. I have actually been covering bitcoin for a long time now. Among the first research reports I ever released was on bitcoin - tech stock. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for any person who followed my recommendation. But at the time of that preliminary suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
But nobody is asking that concern anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. last year. Mass, Mutual is a 150-year-old institution. So think about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the details depends on date as of February 2021, however we could not separately verify this claim. Offered Jeff Brown's past, he likely has a considerable net worth, however we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like capability to choose winning technology stocks. He invested more than 25 years researching technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience offers him an excellent point of view on the market. He's always on the hunt for brand-new opportunities, and he shares much of his finest choices in the Near Future Report.
That's full marks, however it's not absurdly reasoned. Brown has an excellent track record as a stock-picker, and he effectively anticipated a few of the greatest financial occasions of the previous twenty years. Although he doesn't appear to release his choices to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it ideal each time, however Jeff Brown's precise predictions have earned him legions of devoted followers. That says a lot about his capability. The Future Report is released by Brownstone Research study, a prominent financial research study publisher. Brownstone Research study uses a number of research services with a variety of specializations - angel investor.
The company is likewise affiliated with Bonner & Partners, another well-respected research publisher - biotech stocks jeff brown. On its website, Brownstone says its objective is to supply retail investors with professional-grade research study: "For too long, the best investment research study has actually not been available to individual financiers. It has actually been usually booked for financial investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown biotech genome sequencing. The objective of Brownstone Research study is to make that type of exclusive research offered to any investors aiming to get an edge in the marketplaces. The goal is easy to deliver distinct and successful financial investment research found no place else." -Brownstone Research study website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise works as the firm's Chief Financial investment Expert.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to use its clients. After decades of steady success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a home name throughout many of America. If you know even a bit about the marketplace, you know that he has a reputation as a King Midas of sorts. jeff brown 2020 predictions. Whatever he touches turns to gold! Jeff is well mindful of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In truth, Brown thinks S.A.V. jeff brown 2020 predictions. could be "the most significant trend of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be marrying 2 cutting-edge technologies: artificial intelligence and electric automobiles. Musk hopes the combination will assist him develop the first fully-autonomous, self-driving automobiles ever. It's nothing short of the vehicle industry's Holy Grail. As you understand, electric automobiles and self-driving vehicle stocks have actually been huge this year, however the Wall Street machine has approved hype without much concrete result. In spite of a drastic boost in competitors over the past few years, Brown still believes Musk has the very best possibility of putting all of it together.
tech could be the magic string that connects it all together. S.A.V. represents Shared Autonomous Car, and it could be the future of transport. Essentially, this technology would permit you to lease your car as an autonomous, self-driving taxi when you're not utilizing it. You simply leave the automobile and press a button on an app that tells the cars and truck to "sign up with the fleet." Next thing you understand, you're unwinding on your sofa while your car shuttles ride-sharers around town. Most importantly, you get to keep a substantial chunk of the earnings. It sounds crazy, but it could be closed than you believe.